SlideShare a Scribd company logo
1 of 26
Screeningul CCU
2013
O analiza SWOT
Dan Pletea, Elena Popa -Iasi
De ce screening-ul CCU a devenit o
problema in Romania ?
• -Incidenta CCU in Romania
• RO: Orientarea spre screeninguri oportuniste, cu
plata, incluse in consultatia OG)
• -Sistemul de asigurari (preventie vs servicii
curative)
• -Educatie slaba a populatiei
• -Dotarea modesta a cabinetelor MF asociata cu
lacune in pregatirea practica
Incidenţa
şi
mortalitatea
prin cancer
de col uterin,
Europa, 2008
SWOT-Puncte tari:
 Cel mai important proiect de preventie 2012-2013(san, CCU,
colorectal)
 Proiect POSDRU, Finantarea proiectului de educatie de catre
CMR
 Pachete EMC ptru 2 skills-uri (1. comunicarea medic pacient,
2. examinarea pelvina cu recoltarea FCD, sfat oncogenetic
(acolo unde este cazul)
*Analiza SWOT nu face referire la proiectul de training
POSDRU al instructorilor MF
SWOT-Puncte tari:
Implementarea screeningului CCU:
• - Instruirea partea practica :
manechinul , ghidurile MS, EU etc,
resursele internet, experienta UE
- FS1 gestionata de MF
CIRCUITUL INFORMATIEI
Laboratoarele de
citologie
Cabinetele de
ginecologie
Cabinetele medicilor
de familie
Centrele de prelevare a
frotiurilor
Centrele de tratament si
urmarire in timp
NORMELE EUROPENE
Istoria naturala a bolii
Munoz N (2003). Monographs N°31
HPVHPV
HPV NON ONCOGENE
risc scăzut
6, 11 cele mai frecvente
Altele : 40, 42, 43, 44,
54, 61, 70, 72, 81
HPV ONCOGENEHPV ONCOGENE
RisRisc înaltc înalt (HR)(HR)
16, 1816, 18 cele maicele mai frfrecvecvententee
AAlteleltele :: 31, 33, 35, 39, 45, 51,31, 33, 35, 39, 45, 51,
52, 56, 58, 59, 68, 73 et 8252, 56, 58, 59, 68, 73 et 82
HPV: genotipuri
LABO RATO R DE AN ATO M IE PATO LO G ICĂ - CITO LO G IE
Form ular cod F -5.8-1, R ev. 0
R A P O R T D E A N A LIZ Ă C ITO LO G IC Ă : T est B abeş - P apan icolau nr.
N u m e, pren um e: 2 V arsta: 31 an i
D ata p rim irii p ro bei: 18/ 07/ 2012
P rob a: FC D
Indicatie: S C R E E N IN G
M edic: D R .
S istem B E T H E S D A
F ro tiu co nven tio nal/ colo ratie P ap anicolau: adecvat ■ ; insuficient □ ; nesatisfacator □ ;
□ N egativ p en tru leziun e intraepiteliala sau m alig nitate (NILM );
D iagn o stic d escriptiv:
I. M o dificari celulare ben ig ne
In fectii: Trichom onas □ ; C andida □ ; B acterii ■; G ardnerella □ ; H erpes □ ;
M o dificari celulare aso ciate cu: inflam atie ■; D IU □; atrofie □; iradiere □ ;
C elu le en do m etriale > 40 an i □ ;
II. A n o m alii celu lare:
C elule scu am o ase:
A S C -U S □ (celule scuam oase atipice cu sem nificaţie nedeterm inată);
A S C -H □ (celule scuam oase atipice, nu se exclu de o leziune intraepitelială de grad înalt);
LG S IL ■ (leziune intraepitelială de grad scăzut); H P V □ ;
H G S IL □ (leziune intraepitelială de grad înalt );
C arcin om in vaziv □ ;
C elu le g lan d ulare:
A G C - N O S □ (celule glandulare atipice fara alta sem nificaţie specificata)
A G C □ (celule glandulare atipice) endocervicale □ , endom etriale □;
A IS □ (adenocarcinom endo cervical in situ); A d en o ca rcinom : endoc ervical □ ; endom etrial □ ; extrauterin □;
III. E valu are ho rm on ala:
A spect horm ona l com p atibil cu varsta si ana m n eza ■;
A spect horm ona l inco m pa tib il cu varsta si a na m neza □;
N u poa te fi evaluat □;
C aracte rizare g ene rala:
Frotiu in lim ite n orm ale □ ;
M od ificari celulare ben ign e □;
A nom alii a le celule lor epiteliale ■;
D iag no stic citolo g ic: L S IL – H P V (disp laz ie u so ara)
D escriere citolog ica:
C elule s cuam o ase superficiale si interm ediare, un ele cu efect citop atic H P V (halou perinu clear si
binucleere, atipii nu cleare uso are), m etaplazie scuam oasa de tip m a tur si im atur, c elule endoc ervica le,
exudat inflam ato r fibrin o-leuco citar, flora co cco-ba cilara.
R eco m and a ri:
de urm arit evolutia ■; colposcopie ■ ; biopsie □; chiuretaj biopsic □ ; tipare virala ■ ; repetarea F C D dupa tratam ent ■;
D R . S IM O N A M U S C A
M edic prim ar anato m ie patolo gica D ata eliberarii rezultatu lui: /07 / 20 12
LABO RATO R DE AN ATO MIE PATO LO G ICĂ - CITO LO G IE
Form ular cod F-5.8-1, Rev. 0
R A P O R T D E A N A LIZĂ C ITO LO G IC Ă : Test B abeş- P apan icolau nr.
N um e, prenum e: 3 Varsta: 40 ani
D ata prim irii probei: 18/ 07/ 2012
Proba: FC D
Indicatie: SC R EEN IN G
M edic: D R.
Sistem BETHES DA
Frotiu conventional/ coloratie Papanicolau: adecvat ■; insuficient □; nesatisfacator □;
□ Negativ pentru leziune intraepiteliala sau m alignitate (NILM );
D iagnostic descriptiv:
I. M odificari celulare benigne
Infectii: Trichom onas □; C andida □; Bacterii ■; G ardnerella □; H erpes □;
M odificari celulare asociate cu: inflam atie ■; D IU □; atrofie □; iradiere □;
C elule endom etriale > 40 ani □;
II. A nom alii celulare:
C elule scuam oase:
A SC -U S □ (celule scuam oase atipice cu sem nificaţie nedeterm inată);
A SC -H □ (celule scuam oase atipice, nu se exclu de o leziune intraepitelială de grad înalt);
LG SIL □ (leziune intraepitelială de grad scăzut); H PV □;
H G SIL ■ (leziune intraepitelială de grad înalt );
C arcinom invaziv □;
C elule glandulare:
A G C - N O S □ (celule glandulare atipice fara alta sem nificaţie specificata)
A G C □ (celule glandulare atipice) endocervicale □, endom etriale □;
AIS □ (adenocarcinom endocervical in situ); A denocarcinom : endocervical □; endom etrial □; extrauterin □;
III. Evaluare horm on ala:
Aspect horm onal com patibil cu varsta si anam neza ■;
Aspect horm onal incom patibil cu varsta si a nam neza □;
N u poate fi evaluat □;
C aracterizare generala:
Frotiu in lim ite norm ale □ ;
M odificari celulare benigne □;
A nom alii ale celulelor epiteliale ■;
D iagnostic citologic: H G -SIL , cu ex tindere glan dulara (nu se exclu de inva zia)
D escriere citologica:
C elule exo cervica le interm ediare si parab azale dispuse izolat si in g rupuri com pacte, hipercrom e, cu
aspect sincitial, atipii citonucleare: m o dificarea raportu lui N/C , hip ercrom azie si ple om orfism nucle ar,
m em bran a nucleara nereg ulata, nucleoli evid enti, celule endo cervicale, nuclei liberi, m ucus, exu dat
inflam ator fibrino-leuco citar, diateza hem oragica, flora co co-bacilara.
R ecom andari:
de urm arit evolutia ■; colposcopie / biopsie ■; chiuretaj biopsic □; tipare virala □; repetarea FC D dupa tratam ent □;
D R . SIM O N A M U SC A
M edic prim ar anato m ie patolo gica D ata eliberarii rezultatu lui: /07 / 2012
Managementul screeningului CCU in
cabinetul MF -
Puncte slabe(1):
  Neimplicarea instructorilor MF 
in elaborarea curriculei 
 Completarea in  curricula a 
unor elemente esentiale 
(elementele de examinare 
pelvina, tehnica de recoltare - 
practic si Clasificarea Bethesta)
Puncte slabe(2):
 Managementul proiectului: 
Pregatirea a 6600 MF din 
totalul de 11400 vs tinta 
screening la 80% femei
Puncte slabe(3):
   -Implementarea frotiului Pap 
conventional fara testare HPV
– Implementarea screening-ului 
pentru femeile de peste 25 ani; 
– se impune screening-ul de la
21 ani
Riscuri:
 
 preluarea screening-ului de lanturi 
medicale “oportuniste” 
 Intarzieri in finantarea screeningului 
Rezultate
2013:
4 % din femeile examinate 
au leziuni suspecte
Focus pe educatia
pacientilor dar si a
medicilor MF
Un nou capitol
Oncogenetica
Concluzii finale
 1.In reteaua primara se pot depista precoce a 4 
tipuri de cancere: cancerul de col uterin, san, 
colon si prostata. 
2.Incidenta crescuta a cancerului de col uterin in 
Romania a obligat decidentii  la o noua politica 
cu accent pe preventie
Concluzii finale
 3.Continuarea si finantarea 
screeningului CCU este singura 
solutie de a reduce mortalitatea.
4.Pregatirea trebuie continuata in 
2013 pentru a cuprinde  toti medicii 
din urban si rural.
SEMPER AMICI

More Related Content

Featured

2024 State of Marketing Report – by Hubspot
2024 State of Marketing Report – by Hubspot2024 State of Marketing Report – by Hubspot
2024 State of Marketing Report – by HubspotMarius Sescu
 
Everything You Need To Know About ChatGPT
Everything You Need To Know About ChatGPTEverything You Need To Know About ChatGPT
Everything You Need To Know About ChatGPTExpeed Software
 
Product Design Trends in 2024 | Teenage Engineerings
Product Design Trends in 2024 | Teenage EngineeringsProduct Design Trends in 2024 | Teenage Engineerings
Product Design Trends in 2024 | Teenage EngineeringsPixeldarts
 
How Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental HealthHow Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental HealthThinkNow
 
AI Trends in Creative Operations 2024 by Artwork Flow.pdf
AI Trends in Creative Operations 2024 by Artwork Flow.pdfAI Trends in Creative Operations 2024 by Artwork Flow.pdf
AI Trends in Creative Operations 2024 by Artwork Flow.pdfmarketingartwork
 
PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024Neil Kimberley
 
Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)contently
 
How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024Albert Qian
 
Social Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie InsightsSocial Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie InsightsKurio // The Social Media Age(ncy)
 
Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024Search Engine Journal
 
5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summarySpeakerHub
 
ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd Clark Boyd
 
Getting into the tech field. what next
Getting into the tech field. what next Getting into the tech field. what next
Getting into the tech field. what next Tessa Mero
 
Google's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search IntentGoogle's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search IntentLily Ray
 
Time Management & Productivity - Best Practices
Time Management & Productivity -  Best PracticesTime Management & Productivity -  Best Practices
Time Management & Productivity - Best PracticesVit Horky
 
The six step guide to practical project management
The six step guide to practical project managementThe six step guide to practical project management
The six step guide to practical project managementMindGenius
 
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...RachelPearson36
 

Featured (20)

2024 State of Marketing Report – by Hubspot
2024 State of Marketing Report – by Hubspot2024 State of Marketing Report – by Hubspot
2024 State of Marketing Report – by Hubspot
 
Everything You Need To Know About ChatGPT
Everything You Need To Know About ChatGPTEverything You Need To Know About ChatGPT
Everything You Need To Know About ChatGPT
 
Product Design Trends in 2024 | Teenage Engineerings
Product Design Trends in 2024 | Teenage EngineeringsProduct Design Trends in 2024 | Teenage Engineerings
Product Design Trends in 2024 | Teenage Engineerings
 
How Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental HealthHow Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental Health
 
AI Trends in Creative Operations 2024 by Artwork Flow.pdf
AI Trends in Creative Operations 2024 by Artwork Flow.pdfAI Trends in Creative Operations 2024 by Artwork Flow.pdf
AI Trends in Creative Operations 2024 by Artwork Flow.pdf
 
Skeleton Culture Code
Skeleton Culture CodeSkeleton Culture Code
Skeleton Culture Code
 
PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024
 
Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)
 
How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024
 
Social Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie InsightsSocial Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie Insights
 
Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024
 
5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary
 
ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd
 
Getting into the tech field. what next
Getting into the tech field. what next Getting into the tech field. what next
Getting into the tech field. what next
 
Google's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search IntentGoogle's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search Intent
 
How to have difficult conversations
How to have difficult conversations How to have difficult conversations
How to have difficult conversations
 
Introduction to Data Science
Introduction to Data ScienceIntroduction to Data Science
Introduction to Data Science
 
Time Management & Productivity - Best Practices
Time Management & Productivity -  Best PracticesTime Management & Productivity -  Best Practices
Time Management & Productivity - Best Practices
 
The six step guide to practical project management
The six step guide to practical project managementThe six step guide to practical project management
The six step guide to practical project management
 
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
 

Analiza swot ccu

  • 1. Screeningul CCU 2013 O analiza SWOT Dan Pletea, Elena Popa -Iasi
  • 2. De ce screening-ul CCU a devenit o problema in Romania ? • -Incidenta CCU in Romania • RO: Orientarea spre screeninguri oportuniste, cu plata, incluse in consultatia OG) • -Sistemul de asigurari (preventie vs servicii curative) • -Educatie slaba a populatiei • -Dotarea modesta a cabinetelor MF asociata cu lacune in pregatirea practica
  • 4.
  • 5. SWOT-Puncte tari:  Cel mai important proiect de preventie 2012-2013(san, CCU, colorectal)  Proiect POSDRU, Finantarea proiectului de educatie de catre CMR  Pachete EMC ptru 2 skills-uri (1. comunicarea medic pacient, 2. examinarea pelvina cu recoltarea FCD, sfat oncogenetic (acolo unde este cazul) *Analiza SWOT nu face referire la proiectul de training POSDRU al instructorilor MF
  • 6. SWOT-Puncte tari: Implementarea screeningului CCU: • - Instruirea partea practica : manechinul , ghidurile MS, EU etc, resursele internet, experienta UE - FS1 gestionata de MF
  • 7. CIRCUITUL INFORMATIEI Laboratoarele de citologie Cabinetele de ginecologie Cabinetele medicilor de familie Centrele de prelevare a frotiurilor Centrele de tratament si urmarire in timp
  • 8.
  • 9.
  • 10.
  • 13. Munoz N (2003). Monographs N°31 HPVHPV HPV NON ONCOGENE risc scăzut 6, 11 cele mai frecvente Altele : 40, 42, 43, 44, 54, 61, 70, 72, 81 HPV ONCOGENEHPV ONCOGENE RisRisc înaltc înalt (HR)(HR) 16, 1816, 18 cele maicele mai frfrecvecvententee AAlteleltele :: 31, 33, 35, 39, 45, 51,31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73 et 8252, 56, 58, 59, 68, 73 et 82 HPV: genotipuri
  • 14.
  • 15. LABO RATO R DE AN ATO M IE PATO LO G ICĂ - CITO LO G IE Form ular cod F -5.8-1, R ev. 0 R A P O R T D E A N A LIZ Ă C ITO LO G IC Ă : T est B abeş - P apan icolau nr. N u m e, pren um e: 2 V arsta: 31 an i D ata p rim irii p ro bei: 18/ 07/ 2012 P rob a: FC D Indicatie: S C R E E N IN G M edic: D R . S istem B E T H E S D A F ro tiu co nven tio nal/ colo ratie P ap anicolau: adecvat ■ ; insuficient □ ; nesatisfacator □ ; □ N egativ p en tru leziun e intraepiteliala sau m alig nitate (NILM ); D iagn o stic d escriptiv: I. M o dificari celulare ben ig ne In fectii: Trichom onas □ ; C andida □ ; B acterii ■; G ardnerella □ ; H erpes □ ; M o dificari celulare aso ciate cu: inflam atie ■; D IU □; atrofie □; iradiere □ ; C elu le en do m etriale > 40 an i □ ; II. A n o m alii celu lare: C elule scu am o ase: A S C -U S □ (celule scuam oase atipice cu sem nificaţie nedeterm inată); A S C -H □ (celule scuam oase atipice, nu se exclu de o leziune intraepitelială de grad înalt); LG S IL ■ (leziune intraepitelială de grad scăzut); H P V □ ; H G S IL □ (leziune intraepitelială de grad înalt ); C arcin om in vaziv □ ; C elu le g lan d ulare: A G C - N O S □ (celule glandulare atipice fara alta sem nificaţie specificata) A G C □ (celule glandulare atipice) endocervicale □ , endom etriale □; A IS □ (adenocarcinom endo cervical in situ); A d en o ca rcinom : endoc ervical □ ; endom etrial □ ; extrauterin □; III. E valu are ho rm on ala: A spect horm ona l com p atibil cu varsta si ana m n eza ■; A spect horm ona l inco m pa tib il cu varsta si a na m neza □; N u poa te fi evaluat □; C aracte rizare g ene rala: Frotiu in lim ite n orm ale □ ; M od ificari celulare ben ign e □; A nom alii a le celule lor epiteliale ■; D iag no stic citolo g ic: L S IL – H P V (disp laz ie u so ara) D escriere citolog ica: C elule s cuam o ase superficiale si interm ediare, un ele cu efect citop atic H P V (halou perinu clear si binucleere, atipii nu cleare uso are), m etaplazie scuam oasa de tip m a tur si im atur, c elule endoc ervica le, exudat inflam ato r fibrin o-leuco citar, flora co cco-ba cilara. R eco m and a ri: de urm arit evolutia ■; colposcopie ■ ; biopsie □; chiuretaj biopsic □ ; tipare virala ■ ; repetarea F C D dupa tratam ent ■; D R . S IM O N A M U S C A M edic prim ar anato m ie patolo gica D ata eliberarii rezultatu lui: /07 / 20 12 LABO RATO R DE AN ATO MIE PATO LO G ICĂ - CITO LO G IE Form ular cod F-5.8-1, Rev. 0 R A P O R T D E A N A LIZĂ C ITO LO G IC Ă : Test B abeş- P apan icolau nr. N um e, prenum e: 3 Varsta: 40 ani D ata prim irii probei: 18/ 07/ 2012 Proba: FC D Indicatie: SC R EEN IN G M edic: D R. Sistem BETHES DA Frotiu conventional/ coloratie Papanicolau: adecvat ■; insuficient □; nesatisfacator □; □ Negativ pentru leziune intraepiteliala sau m alignitate (NILM ); D iagnostic descriptiv: I. M odificari celulare benigne Infectii: Trichom onas □; C andida □; Bacterii ■; G ardnerella □; H erpes □; M odificari celulare asociate cu: inflam atie ■; D IU □; atrofie □; iradiere □; C elule endom etriale > 40 ani □; II. A nom alii celulare: C elule scuam oase: A SC -U S □ (celule scuam oase atipice cu sem nificaţie nedeterm inată); A SC -H □ (celule scuam oase atipice, nu se exclu de o leziune intraepitelială de grad înalt); LG SIL □ (leziune intraepitelială de grad scăzut); H PV □; H G SIL ■ (leziune intraepitelială de grad înalt ); C arcinom invaziv □; C elule glandulare: A G C - N O S □ (celule glandulare atipice fara alta sem nificaţie specificata) A G C □ (celule glandulare atipice) endocervicale □, endom etriale □; AIS □ (adenocarcinom endocervical in situ); A denocarcinom : endocervical □; endom etrial □; extrauterin □; III. Evaluare horm on ala: Aspect horm onal com patibil cu varsta si anam neza ■; Aspect horm onal incom patibil cu varsta si a nam neza □; N u poate fi evaluat □; C aracterizare generala: Frotiu in lim ite norm ale □ ; M odificari celulare benigne □; A nom alii ale celulelor epiteliale ■; D iagnostic citologic: H G -SIL , cu ex tindere glan dulara (nu se exclu de inva zia) D escriere citologica: C elule exo cervica le interm ediare si parab azale dispuse izolat si in g rupuri com pacte, hipercrom e, cu aspect sincitial, atipii citonucleare: m o dificarea raportu lui N/C , hip ercrom azie si ple om orfism nucle ar, m em bran a nucleara nereg ulata, nucleoli evid enti, celule endo cervicale, nuclei liberi, m ucus, exu dat inflam ator fibrino-leuco citar, diateza hem oragica, flora co co-bacilara. R ecom andari: de urm arit evolutia ■; colposcopie / biopsie ■; chiuretaj biopsic □; tipare virala □; repetarea FC D dupa tratam ent □; D R . SIM O N A M U SC A M edic prim ar anato m ie patolo gica D ata eliberarii rezultatu lui: /07 / 2012
  • 16. Managementul screeningului CCU in cabinetul MF -
  • 17. Puncte slabe(1):   Neimplicarea instructorilor MF  in elaborarea curriculei   Completarea in  curricula a  unor elemente esentiale  (elementele de examinare  pelvina, tehnica de recoltare -  practic si Clasificarea Bethesta)
  • 22. Focus pe educatia pacientilor dar si a medicilor MF